\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ esr\\ and\\ b2\\ microglobulin\ \(0\)\
\-\ igg\\ gamma\\ monoclonocal\\ gammopathy\ \(0\)\
\-\ she\\ was\\ noted\\ to\\ have\\ lytic\\ lesions\\ in\\ the\\ vertebral\\ bodies\\ on\\ a\\ high\\-resolution\\ chest\\ ct\\.\\ \\ biopsy\\ was\\ performed\\ of\\ the\\ seventh\\ vertebral\\ body\\.\\ biopsy\\ demonstrated\\ atypical\\ plasma\\ cells\\ with\\ the\\ characteristic\\ plasma\\ cell\\ phenotype\\ \\+cd38\\ and\\ cytokeratin\\ negative\\.\ \(0\)\
\-\ ct\\-guided\\ biopsy\\ of\\ the\\ seventh\\ thoracic\\ vertebral\\ body\\ lytic\\ lesion\\ was\\ performed\\.\\ \\ other\\ lesions\\ were\\ seen\\ at\\ t3\\ and\\ t12\\ \\(not\\ depicted\\)\\.\ \(0\)\
\-\ subsequently\\,\\ mri\\ of\\ the\\ spine\\ was\\ performed\\.\\ \\ here\\,\\ multiple\\ lesions\\ are\\ seen\\ on\\ both\\ t1\\-\\ and\\ t2\\-weighted\\ sagittal\\ images\\ which\\ are\\ hypointense\\ compared\\ to\\ the\\ vertebral\\ bodies\ \(0\)\
\-\ multiple\\ myeloma\ \(25\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ multiple\\ myeloma\ \(25\)\
\-\ lymphoma\ \(373\)\
\-\ infection\ \(713\)\
\-\ 72\\ y\\.o\\.\\ woman\\ with\\ anemia\\ and\\ paraproteinemia\\.\ \(0\)\
\-\ she\\ was\\ noted\\ to\\ have\\ lytic\\ lesions\\ in\\ the\\ vertebral\\ bodies\\ on\\ a\\ high\\-resolution\\ chest\\ ct\\.\\ \\ biopsy\\ was\\ performed\\ of\\ the\\ seventh\\ vertebral\\ body\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vertebral\\:\\ 0\\.13527185681649034\ \(0\)\
\-\ seventh\\:\\ 0\\.12214936445728576\ \(0\)\
\-\ high\\-resolution\\:\\ 0\\.08824391795507039\ \(0\)\
\-\ biopsy\\:\\ 0\\.08084515311031362\ \(0\)\
\-\ bodies\\:\\ 0\\.08006668137188161\ \(0\)\
\-\ plasma\\:\\ 0\\.07694661314990767\ \(0\)\
\-\ lytic\\:\\ 0\\.07650171674375524\ \(0\)\
\-\ myeloma\\:\\ 0\\.06620494429675254\ \(0\)\
\-\ performed\\:\\ 0\\.06353542216606184\ \(0\)\
\-\ lesions\\:\\ 0\\.06100161350250528\ \(0\)\
\-\ b2\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ \\-igg\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ monoclonocal\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ \\+cd38\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ paraproteinemia\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ body\\:\\ 0\\.05550527425378169\ \(0\)\
\-\ microglobulin\\:\\ 0\\.05414914162271035\ \(0\)\
\-\ \\-elevated\\:\\ 0\\.05144604090198926\ \(0\)\
\-\ gammopathy\\:\\ 0\\.05144604090198926\ \(0\)\
\-\ t1\\-\\:\\ 0\\.05144604090198926\ \(0\)\
\-\ phenotype\\:\\ 0\\.04804053674354932\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.045797388499407905\ \(0\)\
\-\ depicted\\:\\ 0\\.044121958977535194\ \(0\)\
\-\ ct\\-guided\\:\\ 0\\.04341955553981635\ \(0\)\
\-\ t12\\:\\ 0\\.04167046044336641\ \(0\)\
\-\ was\\:\\ 0\\.03953110088854747\ \(0\)\
\-\ t3\\:\\ 0\\.03679787705308113\ \(0\)\
\-\ multiple\\:\\ 0\\.03599612006958538\ \(0\)\
\-\ gamma\\:\\ 0\\.03451954842826742\ \(0\)\
\-\ 72\\:\\ 0\\.03230151006942918\ \(0\)\
\-\ she\\:\\ 0\\.031983815219388964\ \(0\)\
\-\ here\\:\\ 0\\.02972539731517938\ \(0\)\
\-\ esr\\:\\ 0\\.028845880361562392\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.028845880361562392\ \(0\)\
\-\ anemia\\:\\ 0\\.028341134883324418\ \(0\)\
\-\ chest\\:\\ 0\\.02726305333410025\ \(0\)\
\-\ hypointense\\:\\ 0\\.027022296594458282\ \(0\)\
\-\ noted\\:\\ 0\\.027005615846034583\ \(0\)\
\-\ subsequently\\:\\ 0\\.025825840009047963\ \(0\)\
\-\ atypical\\:\\ 0\\.0246902042373997\ \(0\)\
\-\ have\\:\\ 0\\.02467250771153456\ \(0\)\
\-\ characteristic\\:\\ 0\\.02411347595133782\ \(0\)\
\-\ compared\\:\\ 0\\.02411347595133782\ \(0\)\
\-\ cells\\:\\ 0\\.022842977960999985\ \(0\)\
\-\ sagittal\\:\\ 0\\.0227223110167092\ \(0\)\
\-\ seen\\:\\ 0\\.022515034867569204\ \(0\)\
\-\ thoracic\\:\\ 0\\.021960383374028346\ \(0\)\
\-\ spine\\:\\ 0\\.01876069030670232\ \(0\)\
\-\ negative\\:\\ 0\\.01701413440916583\ \(0\)\
\-\ demonstrated\\:\\ 0\\.016716133216379783\ \(0\)\
\-\ infection\\:\\ 0\\.016560110493818714\ \(0\)\
\-\ y\\.o\\:\\ 0\\.016442529550578\ \(0\)\
\-\ lymphoma\\:\\ 0\\.01628132422926324\ \(0\)\
\-\ ct\\:\\ 0\\.01593738204522724\ \(0\)\
\-\ are\\:\\ 0\\.015531651633728024\ \(0\)\
\-\ cell\\:\\ 0\\.015388271410543242\ \(0\)\
\-\ both\\:\\ 0\\.014547999937907476\ \(0\)\
\-\ on\\:\\ 0\\.014477820247308561\ \(0\)\
\-\ metastatic\\:\\ 0\\.014340729357440603\ \(0\)\
\-\ woman\\:\\ 0\\.013159352983259376\ \(0\)\
\-\ other\\:\\ 0\\.013130923658016325\ \(0\)\
\-\ mri\\:\\ 0\\.0130885056994308\ \(0\)\
\-\ were\\:\\ 0\\.012935242244599476\ \(0\)\
\-\ lesion\\:\\ 0\\.011603701506669699\ \(0\)\
\-\ images\\:\\ 0\\.010928425946329028\ \(0\)\
\-\ which\\:\\ 0\\.010634297248283658\ \(0\)\
\-\ disease\\:\\ 0\\.009311583608104695\ \(0\)\
\-\ to\\:\\ 0\\.008541362168859725\ \(0\)\
\-\ not\\:\\ 0\\.008232124478279569\ \(0\)\
\-\ at\\:\\ 0\\.007718421018877554\ \(0\)\
\-\ the\\:\\ 0\\.007373295184193376\ \(0\)\
\-\ and\\:\\ 0\\.006000300191073948\ \(0\)\
\-\ in\\:\\ 0\\.005618629735203399\ \(0\)\
\-\ a\\:\\ 0\\.005287997357581351\ \(0\)\
\-\ \\(\\:\\ 0\\.004815744841625737\ \(0\)\
\-\ \\)\\:\\ 0\\.004756917947422034\ \(0\)\
\-\ \\,\\:\\ 0\\.0036094675402304987\ \(0\)\
\-\ of\\:\\ 0\\.0031067680212796918\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
\-\ with\\:\\ 0\\.00156005568119853\ \(0\)\
